Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Janet Rader

Concepts (632)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
84
2022
274
13.480
Why?
Ovarian Neoplasms
37
2024
448
2.910
Why?
Papillomavirus Infections
18
2021
155
2.880
Why?
Endometrial Neoplasms
34
2019
137
2.520
Why?
Uterine Cervical Dysplasia
16
2017
49
2.510
Why?
Carcinoma, Squamous Cell
31
2018
319
2.120
Why?
Gene Expression Regulation, Neoplastic
18
2021
829
1.950
Why?
Human papillomavirus 16
8
2019
44
1.800
Why?
Female
189
2024
26329
1.640
Why?
Gene Expression Profiling
9
2021
1031
1.610
Why?
Papillomaviridae
16
2020
102
1.440
Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
987
1.350
Why?
DNA Methylation
21
2020
548
1.350
Why?
Genital Neoplasms, Female
10
2018
41
1.240
Why?
Human papillomavirus 18
5
2019
9
1.230
Why?
Humans
190
2024
49827
1.190
Why?
Genetic Predisposition to Disease
13
2024
510
1.160
Why?
Adult
92
2024
13160
1.150
Why?
Middle Aged
99
2024
11997
1.090
Why?
Neoplasm Staging
41
2019
746
1.070
Why?
Adenocarcinoma
18
2018
401
1.040
Why?
Polymorphism, Single Nucleotide
10
2019
485
1.010
Why?
Fluorodeoxyglucose F18
15
2022
191
0.990
Why?
MicroRNAs
7
2019
354
0.980
Why?
Neoplasm Recurrence, Local
19
2024
618
0.970
Why?
DNA-Binding Proteins
9
2021
436
0.970
Why?
Carcinoma
12
2010
137
0.940
Why?
Oncogene Proteins, Viral
4
2019
52
0.890
Why?
Radiopharmaceuticals
14
2022
209
0.830
Why?
Cervix Uteri
7
2017
49
0.830
Why?
Repressor Proteins
4
2019
151
0.820
Why?
Alphapapillomavirus
1
2021
13
0.790
Why?
DNA, Viral
6
2019
133
0.770
Why?
Cell Line, Tumor
18
2021
1402
0.750
Why?
Immunologic Factors
2
2014
114
0.740
Why?
Neoplasm Invasiveness
15
2020
268
0.720
Why?
Neoplasms
8
2022
1233
0.710
Why?
Aged
70
2024
9272
0.700
Why?
Genetic Markers
8
2017
103
0.700
Why?
Genes, Tumor Suppressor
8
2007
73
0.700
Why?
Neoplasm Proteins
10
2019
323
0.680
Why?
Immunoglobulins
3
2017
79
0.680
Why?
Genomics
4
2018
282
0.650
Why?
Biomedical Research
1
2022
231
0.650
Why?
Gene Silencing
5
2018
121
0.640
Why?
Vascular Endothelial Growth Factor A
2
2017
201
0.570
Why?
Cisplatin
7
2022
278
0.570
Why?
Aged, 80 and over
36
2024
3125
0.550
Why?
Proteomics
1
2019
328
0.550
Why?
Promoter Regions, Genetic
12
2020
477
0.540
Why?
HLA-C Antigens
2
2018
4
0.540
Why?
Receptors, KIR
2
2018
13
0.540
Why?
Positron-Emission Tomography
11
2013
294
0.520
Why?
Ubiquitin Thiolesterase
2
2021
18
0.520
Why?
Tumor Virus Infections
4
2006
43
0.520
Why?
Microsatellite Repeats
14
2007
37
0.510
Why?
Lymph Nodes
10
2010
264
0.510
Why?
Hysterectomy
15
2022
88
0.500
Why?
Disease-Free Survival
17
2013
457
0.500
Why?
Gynecologic Surgical Procedures
4
2010
30
0.500
Why?
Granulosa Cell Tumor
2
2024
2
0.480
Why?
Phenotype
4
2016
727
0.480
Why?
Prognosis
19
2021
1952
0.470
Why?
Lymphatic Metastasis
14
2019
230
0.460
Why?
Chromosomes, Human, Pair 6
4
2007
15
0.450
Why?
Alleles
5
2017
251
0.450
Why?
Loss of Heterozygosity
10
2007
77
0.450
Why?
Nuclear Proteins
8
2009
243
0.450
Why?
Ovary
2
2008
104
0.430
Why?
Membrane Proteins
3
2005
342
0.420
Why?
Genotype
9
2018
538
0.420
Why?
Cell Movement
5
2021
247
0.410
Why?
Survival Analysis
14
2021
659
0.410
Why?
STAT3 Transcription Factor
3
2021
81
0.410
Why?
Peritoneal Neoplasms
4
2008
60
0.400
Why?
Ultrasonic Therapy
3
2001
32
0.400
Why?
Carcinoma, Endometrioid
6
2014
38
0.400
Why?
Genes, p53
2
2010
51
0.390
Why?
Cell Proliferation
6
2021
1007
0.390
Why?
Risk Factors
13
2019
3619
0.380
Why?
Signal Transduction
8
2021
1617
0.380
Why?
Uterine Neoplasms
5
2009
60
0.370
Why?
Mutation
12
2018
1293
0.370
Why?
Ascites
2
2008
28
0.370
Why?
Carboplatin
2
2009
53
0.370
Why?
Antineoplastic Agents
9
2014
1172
0.360
Why?
Antibodies, Monoclonal
5
2021
458
0.360
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
14
0.360
Why?
Proto-Oncogene Proteins c-mdm2
1
2010
12
0.360
Why?
Cohort Studies
13
2024
1422
0.360
Why?
Disease Progression
6
2020
822
0.350
Why?
GTPase-Activating Proteins
1
2009
23
0.350
Why?
Membrane Glycoproteins
2
2009
240
0.350
Why?
Base Sequence
8
2019
650
0.350
Why?
DNA, Neoplasm
11
2006
147
0.340
Why?
Chromosomes, Human, Pair 11
3
2005
54
0.340
Why?
Matrix Metalloproteinase 9
1
2009
86
0.340
Why?
Neoplasms, Glandular and Epithelial
3
2006
42
0.340
Why?
Brachytherapy
9
2014
48
0.330
Why?
Proto-Oncogene Proteins c-myc
2
2021
50
0.330
Why?
Combined Modality Therapy
11
2010
636
0.330
Why?
Abdominal Neoplasms
1
2009
17
0.330
Why?
DNA Repair
11
2007
192
0.330
Why?
Retrospective Studies
33
2024
6117
0.330
Why?
Laser Coagulation
1
2009
26
0.330
Why?
Drug Administration Schedule
10
2013
376
0.320
Why?
Deoxycytidine
4
2006
27
0.320
Why?
Homeodomain Proteins
2
2006
80
0.310
Why?
RNA-Binding Proteins
2
2021
124
0.310
Why?
Microsatellite Instability
5
2019
17
0.310
Why?
Germ-Line Mutation
3
2024
61
0.310
Why?
Protozoan Proteins
1
2008
31
0.310
Why?
Laparoscopy
3
2022
173
0.310
Why?
Kaplan-Meier Estimate
6
2019
469
0.300
Why?
Drug Resistance, Neoplasm
6
2016
308
0.300
Why?
Ovariectomy
7
2010
119
0.300
Why?
Antigens, CD
2
2007
215
0.290
Why?
Chromosomes, Human, Pair 3
4
2001
19
0.290
Why?
Heart Arrest
1
2009
148
0.290
Why?
SOXC Transcription Factors
2
2019
13
0.290
Why?
Polymerase Chain Reaction
9
2010
455
0.290
Why?
Receptors, Estrogen
3
2024
130
0.280
Why?
Topotecan
5
2013
17
0.280
Why?
POU Domain Factors
1
2006
1
0.280
Why?
Vulvar Neoplasms
5
2002
52
0.270
Why?
Registries
6
2010
518
0.270
Why?
Neoplasm Metastasis
5
2021
231
0.270
Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.270
Why?
HeLa Cells
3
2021
251
0.270
Why?
Anemia
3
2020
68
0.260
Why?
Young Adult
7
2018
3936
0.260
Why?
Survival Rate
10
2009
905
0.260
Why?
Vaginal Smears
6
2006
28
0.260
Why?
Breast Neoplasms
5
2018
1169
0.250
Why?
Immunohistochemistry
12
2024
971
0.250
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
595
0.240
Why?
Chromosome Aberrations
1
2006
298
0.240
Why?
Virus Integration
2
2021
9
0.240
Why?
HSP70 Heat-Shock Proteins
1
2004
62
0.230
Why?
Receptors, Androgen
1
2024
46
0.230
Why?
Receptors, Progesterone
1
2024
63
0.230
Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.230
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.230
Why?
Oncostatin M
2
2021
5
0.230
Why?
Quinazolines
1
2003
33
0.230
Why?
Antigens, Neoplasm
1
2004
151
0.220
Why?
Genome-Wide Association Study
2
2017
166
0.220
Why?
Polymorphism, Genetic
5
2018
181
0.220
Why?
Small Cell Lung Carcinoma
1
2023
26
0.220
Why?
Omentum
1
2002
14
0.220
Why?
Case-Control Studies
7
2019
1128
0.220
Why?
Treatment Outcome
23
2014
5138
0.210
Why?
Chromosome Deletion
3
2000
141
0.210
Why?
Tumor Microenvironment
2
2021
210
0.210
Why?
Linkage Disequilibrium
3
2017
37
0.210
Why?
Proto-Oncogene Proteins c-akt
2
2014
157
0.210
Why?
Neoadjuvant Therapy
2
2022
115
0.210
Why?
Antibodies, Monoclonal, Humanized
5
2013
222
0.200
Why?
Genetic Variation
4
2019
214
0.200
Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.200
Why?
Base Pair Mismatch
5
2006
22
0.200
Why?
CA-125 Antigen
3
2008
17
0.200
Why?
Postoperative Complications
3
2022
1000
0.200
Why?
Chemoradiotherapy
1
2022
40
0.200
Why?
Suction
1
2001
23
0.200
Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.200
Why?
Smoking
1
2005
510
0.190
Why?
Radiotherapy, Conformal
2
2014
53
0.190
Why?
Colorectal Neoplasms
3
2002
234
0.190
Why?
Proteins
5
2008
341
0.190
Why?
Carcinoma in Situ
2
2013
73
0.190
Why?
Adaptor Proteins, Signal Transducing
8
2007
193
0.190
Why?
Antimetabolites, Antineoplastic
2
2002
37
0.190
Why?
Gene Regulatory Networks
2
2019
107
0.190
Why?
Fetofetal Transfusion
1
2020
6
0.190
Why?
Polycythemia
1
2020
9
0.190
Why?
Pregnancy, Twin
1
2020
8
0.190
Why?
Minority Groups
1
2022
132
0.190
Why?
Twins, Monozygotic
1
2020
17
0.190
Why?
Radiotherapy
3
2010
128
0.190
Why?
Sarcoma
3
2009
67
0.180
Why?
Lymph Node Excision
7
2019
136
0.180
Why?
Genetic Diseases, Inborn
1
2000
24
0.180
Why?
Transcriptome
2
2020
313
0.180
Why?
Patient Satisfaction
2
2006
273
0.180
Why?
Receptor, erbB-3
1
2020
1
0.180
Why?
Furin
1
2020
3
0.180
Why?
Phosphoproteins
2
2016
113
0.180
Why?
Receptor, IGF Type 1
1
2020
19
0.180
Why?
HLA-DQ Antigens
1
2000
3
0.180
Why?
Tomography, X-Ray Computed
7
2013
1159
0.180
Why?
Mice, Nude
4
2021
252
0.170
Why?
Tumor Cells, Cultured
7
2021
465
0.170
Why?
RNA, Neoplasm
3
2007
44
0.170
Why?
Students
1
2022
210
0.170
Why?
Prenatal Diagnosis
1
2020
107
0.170
Why?
Antibodies, Neoplasm
1
2019
28
0.170
Why?
Adolescent
13
2018
6340
0.170
Why?
Papillomavirus E7 Proteins
2
2017
31
0.170
Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.170
Why?
Placenta
1
2020
132
0.170
Why?
Reproducibility of Results
2
2022
1188
0.170
Why?
Follow-Up Studies
13
2019
2179
0.160
Why?
Indocyanine Green
1
2019
34
0.160
Why?
Doxorubicin
4
2009
230
0.160
Why?
Decision Making
1
2001
262
0.160
Why?
Fallopian Tube Neoplasms
3
2008
14
0.160
Why?
Salvage Therapy
3
2008
139
0.160
Why?
Cyclooxygenase 2
2
2017
45
0.160
Why?
Sequence Analysis, DNA
1
2019
237
0.150
Why?
Lung Neoplasms
2
2023
605
0.150
Why?
Transcription Factors
1
2021
563
0.150
Why?
HLA-DRB1 Chains
1
2017
4
0.150
Why?
HLA-B Antigens
1
2017
6
0.150
Why?
Metabolic Networks and Pathways
1
2018
89
0.150
Why?
DNA Copy Number Variations
1
2018
110
0.150
Why?
Receptors, Vitronectin
1
1997
1
0.150
Why?
Tumor Suppressor Proteins
3
2005
127
0.150
Why?
Carcinoma, Adenosquamous
3
2009
8
0.150
Why?
Proto-Oncogene Proteins
5
2004
149
0.150
Why?
DNA Mutational Analysis
9
2005
175
0.150
Why?
Interleukin-10
1
2017
84
0.150
Why?
Bayes Theorem
1
2017
108
0.150
Why?
Adipose Tissue
1
2019
187
0.150
Why?
Cyclooxygenase 2 Inhibitors
1
2017
19
0.140
Why?
In Situ Hybridization
3
2008
65
0.140
Why?
Leukocytes, Mononuclear
1
2017
116
0.140
Why?
Protein Binding
1
2019
660
0.140
Why?
Radiotherapy, Intensity-Modulated
2
2009
172
0.140
Why?
Gene Expression Regulation, Viral
1
2017
48
0.140
Why?
Animals
10
2021
13150
0.140
Why?
Risk Assessment
9
2019
1262
0.140
Why?
Body Mass Index
3
2010
652
0.140
Why?
Radiotherapy Dosage
8
2014
243
0.140
Why?
ROC Curve
1
2017
232
0.140
Why?
Radiation Injuries
3
2008
113
0.140
Why?
Taxoids
3
2006
37
0.140
Why?
Carrier Proteins
7
2006
304
0.140
Why?
Biopsy
5
2006
582
0.130
Why?
Prospective Studies
10
2019
2344
0.130
Why?
Estrogens
1
2017
227
0.130
Why?
Colposcopy
3
2006
18
0.130
Why?
Molecular Sequence Data
5
2009
797
0.130
Why?
Wound Healing
2
2018
206
0.130
Why?
Cells, Cultured
2
2017
1571
0.130
Why?
Carcinosarcoma
3
2019
18
0.130
Why?
Double-Blind Method
1
2017
674
0.130
Why?
Sensitivity and Specificity
4
2006
854
0.130
Why?
Algorithms
1
2019
616
0.130
Why?
Apoptosis
2
2021
1100
0.130
Why?
Mice
6
2021
5720
0.130
Why?
Ultrasonography, Doppler, Color
1
1995
33
0.130
Why?
Protein Kinase Inhibitors
2
2014
202
0.120
Why?
Aneurysm
1
1995
33
0.120
Why?
Dose-Response Relationship, Drug
6
2008
1374
0.120
Why?
DNA Primers
2
2006
206
0.120
Why?
Phosphatidylinositol 3-Kinases
2
2014
141
0.120
Why?
Platinum Compounds
4
2008
10
0.120
Why?
Obesity
5
2010
1113
0.120
Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.120
Why?
Cyclohexanones
1
2014
7
0.120
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.120
Why?
Embolization, Therapeutic
1
1995
87
0.120
Why?
Transcriptional Activation
2
2019
122
0.110
Why?
Camptothecin
3
2010
16
0.110
Why?
Genetic Association Studies
1
2014
116
0.110
Why?
TOR Serine-Threonine Kinases
1
2014
77
0.110
Why?
Paclitaxel
4
2007
84
0.110
Why?
Introns
1
2013
49
0.110
Why?
Hypercalcemia
1
1993
33
0.110
Why?
Decision Support Techniques
2
2010
70
0.110
Why?
Chromosome Mapping
3
2005
160
0.110
Why?
Pyridines
1
2014
130
0.110
Why?
Cell Transformation, Neoplastic
2
2006
177
0.110
Why?
Brain Neoplasms
1
2016
286
0.110
Why?
Dermatologic Surgical Procedures
1
1992
34
0.110
Why?
Keratinocytes
2
2006
89
0.100
Why?
Models, Genetic
1
2012
174
0.100
Why?
Tomography, Emission-Computed
4
2005
53
0.100
Why?
Groin
2
2002
16
0.100
Why?
RNA, Messenger
4
2021
1105
0.100
Why?
Glucose
1
2014
340
0.100
Why?
Laser Therapy
1
1992
83
0.100
Why?
Exons
3
2007
95
0.100
Why?
Pyrazoles
2
2023
113
0.100
Why?
Infusions, Intravenous
4
2006
207
0.100
Why?
Heterozygote
2
2004
82
0.100
Why?
Condylomata Acuminata
1
1991
4
0.100
Why?
Magnetic Resonance Imaging
3
2014
1533
0.100
Why?
Epithelium
2
2007
65
0.100
Why?
Models, Statistical
1
2012
225
0.100
Why?
Goserelin
1
2010
1
0.100
Why?
Decision Trees
1
2010
19
0.100
Why?
Estrogen Antagonists
1
2010
21
0.090
Why?
Ileal Diseases
1
1990
4
0.090
Why?
Predictive Value of Tests
6
2010
904
0.090
Why?
Leiomyoma
1
1990
25
0.090
Why?
Epigenesis, Genetic
2
2019
373
0.090
Why?
Cell Differentiation
2
2009
653
0.090
Why?
Polymorphism, Restriction Fragment Length
1
2010
66
0.090
Why?
Restriction Mapping
3
2006
33
0.090
Why?
Gastrointestinal Hemorrhage
1
1990
78
0.090
Why?
Diagnosis, Differential
3
2020
1036
0.090
Why?
Colonic Neoplasms
2
2004
162
0.090
Why?
Skin Transplantation
1
1990
43
0.090
Why?
Age Factors
4
2006
1090
0.090
Why?
Down-Regulation
4
2020
349
0.090
Why?
Maximum Tolerated Dose
5
2010
37
0.090
Why?
Fluorouracil
2
2006
55
0.080
Why?
Endometrium
3
2019
41
0.080
Why?
Genome, Human
2
2008
111
0.080
Why?
Urinary Bladder Diseases
1
2009
18
0.080
Why?
Intestinal Diseases
1
2009
25
0.080
Why?
Lymphatic Vessels
1
2009
46
0.080
Why?
Lasers, Gas
1
2009
7
0.080
Why?
Embolism, Air
1
2009
12
0.080
Why?
Transcription, Genetic
4
2019
371
0.080
Why?
Vaginal Neoplasms
2
2005
4
0.080
Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
Why?
Fluorine Radioisotopes
1
2008
24
0.080
Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
Why?
Infertility, Female
1
2008
18
0.080
Why?
Eimeria
1
2008
3
0.080
Why?
Haplotypes
2
2017
83
0.080
Why?
Ubiquitin
1
2008
45
0.080
Why?
Polyethylene Glycols
2
2006
96
0.080
Why?
Up-Regulation
2
2020
450
0.080
Why?
Cell Cycle Proteins
1
2009
166
0.080
Why?
Cricetinae
1
2008
192
0.080
Why?
Expressed Sequence Tags
1
2007
8
0.080
Why?
Tumor Burden
2
2021
132
0.080
Why?
Angiogenesis Inhibitors
2
2006
187
0.080
Why?
Infusion Pumps
1
1987
13
0.080
Why?
Fluorescent Antibody Technique
1
2007
108
0.080
Why?
Diagnostic Imaging
1
2009
176
0.080
Why?
Microdissection
1
2007
19
0.070
Why?
Precancerous Conditions
2
2005
83
0.070
Why?
MutS Homolog 2 Protein
5
2007
12
0.070
Why?
Models, Biological
2
2008
728
0.070
Why?
Aorta
3
2005
160
0.070
Why?
Stromal Cells
1
2007
72
0.070
Why?
Organ Specificity
2
2018
108
0.070
Why?
Pelvic Floor
1
2007
48
0.070
Why?
Codon
2
2003
47
0.070
Why?
Lasers
1
2007
119
0.070
Why?
RNA, Double-Stranded
1
2006
21
0.070
Why?
Polymorphism, Single-Stranded Conformational
6
2003
19
0.070
Why?
Recombinant Proteins
1
2008
486
0.070
Why?
Neutropenia
1
2007
117
0.070
Why?
Tissue Fixation
1
2006
36
0.070
Why?
Intestinal Perforation
2
2006
23
0.070
Why?
Head and Neck Neoplasms
2
2016
268
0.070
Why?
Specimen Handling
1
2006
54
0.070
Why?
Pulmonary Embolism
1
1987
97
0.070
Why?
Protein Kinases
1
2006
72
0.070
Why?
Chromosomes, Artificial, Yeast
3
2000
6
0.070
Why?
Endometrial Hyperplasia
2
2002
14
0.060
Why?
Proportional Hazards Models
4
2010
406
0.060
Why?
Abdomen
1
2006
79
0.060
Why?
Papillomavirus Vaccines
1
2006
61
0.060
Why?
Recurrence
4
2010
651
0.060
Why?
Probability
4
2007
164
0.060
Why?
Terminal Care
1
2005
45
0.060
Why?
Dibenzocycloheptenes
1
2004
1
0.060
Why?
Neovascularization, Pathologic
1
2006
161
0.060
Why?
Male
11
2018
25093
0.060
Why?
Tumor Suppressor Protein p53
1
2006
202
0.060
Why?
Quinolines
1
2004
39
0.060
Why?
Radiation-Sensitizing Agents
1
2005
53
0.060
Why?
Cell Adhesion Molecules
1
2005
85
0.060
Why?
Amyloid
1
2004
27
0.060
Why?
Tissue Distribution
1
2004
164
0.060
Why?
Genes, Viral
1
2003
38
0.060
Why?
Lactones
1
2003
26
0.060
Why?
Abdomen, Acute
1
2003
6
0.060
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
245
0.060
Why?
Thrombospondins
1
2003
8
0.060
Why?
Biopsy, Needle
4
2006
183
0.060
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
57
0.060
Why?
Pyrimidinones
1
2023
17
0.060
Why?
Obesity, Morbid
1
2004
78
0.060
Why?
RNA, Viral
2
2016
125
0.060
Why?
Neoplasms, Second Primary
1
2004
69
0.060
Why?
Fibroma
1
2003
39
0.060
Why?
Clinical Competence
1
2006
398
0.050
Why?
Radiotherapy, Adjuvant
3
2010
57
0.050
Why?
Congenital Abnormalities
1
2004
112
0.050
Why?
Uterine Hemorrhage
1
2002
11
0.050
Why?
Age of Onset
2
2004
106
0.050
Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
Why?
PTEN Phosphohydrolase
2
2019
55
0.050
Why?
DNA, Ribosomal
1
2002
25
0.050
Why?
Blood Transfusion, Autologous
1
2002
4
0.050
Why?
Chromatography, High Pressure Liquid
1
2003
349
0.050
Why?
Genital Diseases, Female
1
2002
17
0.050
Why?
Acridines
1
2002
4
0.050
Why?
Medical History Taking
1
2002
47
0.050
Why?
Pregnancy
3
2020
2584
0.050
Why?
Medical Records
1
2002
83
0.050
Why?
Blood Donors
1
2002
31
0.050
Why?
Complementary Therapies
1
2002
25
0.050
Why?
AU Rich Elements
1
2021
1
0.050
Why?
Family Health
1
2002
80
0.050
Why?
Postmenopause
1
2002
100
0.050
Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
Why?
RNA Stability
1
2021
24
0.050
Why?
Cytokine Receptor gp130
1
2021
12
0.050
Why?
Receptors, Transforming Growth Factor beta
1
2001
25
0.050
Why?
3' Untranslated Regions
1
2021
52
0.050
Why?
Lymphatic Irradiation
1
2001
1
0.050
Why?
Blotting, Northern
2
2001
109
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2001
26
0.050
Why?
Blotting, Southern
3
2002
43
0.050
Why?
Xenograft Model Antitumor Assays
1
2021
210
0.050
Why?
Phosphoric Monoester Hydrolases
1
2000
22
0.050
Why?
Equipment Design
1
2001
282
0.050
Why?
Internship and Residency
1
2006
446
0.050
Why?
Blood Vessels
1
2001
72
0.050
Why?
Uganda
1
2020
36
0.050
Why?
Catheterization, Central Venous
1
2001
87
0.050
Why?
Isoenzymes
1
2001
168
0.050
Why?
Risk Management
1
2000
32
0.050
Why?
Logistic Models
2
2017
891
0.050
Why?
Incidence
3
2007
1003
0.050
Why?
Physical Chromosome Mapping
1
2000
8
0.050
Why?
Quality Improvement
1
2022
212
0.050
Why?
beta Karyopherins
1
2019
4
0.040
Why?
Interviews as Topic
1
2001
258
0.040
Why?
Patient Discharge
1
2022
322
0.040
Why?
Acid Anhydride Hydrolases
1
1999
15
0.040
Why?
Cell Survival
1
2021
598
0.040
Why?
DNA Repair Enzymes
1
1999
43
0.040
Why?
Adenosine Triphosphatases
1
1999
87
0.040
Why?
Cell Nucleus
1
2019
184
0.040
Why?
Cross-Sectional Studies
1
2024
1541
0.040
Why?
Molecular Targeted Therapy
1
2019
119
0.040
Why?
Regression Analysis
3
2006
395
0.040
Why?
Pregnancy Outcome
1
2020
237
0.040
Why?
Chromosomes, Human, Pair 10
1
1998
3
0.040
Why?
Coloring Agents
1
2019
71
0.040
Why?
Cystadenocarcinoma, Serous
1
2019
70
0.040
Why?
Gene Dosage
1
2018
78
0.040
Why?
Histone Demethylases
1
2018
16
0.040
Why?
Th1-Th2 Balance
1
2018
2
0.040
Why?
Epithelial-Mesenchymal Transition
1
2018
47
0.040
Why?
Leptin
1
2019
140
0.040
Why?
Major Histocompatibility Complex
1
2017
11
0.040
Why?
Databases, Genetic
1
2018
88
0.040
Why?
Genotyping Techniques
1
2017
20
0.040
Why?
Estradiol
1
2019
225
0.040
Why?
Child
4
2018
6824
0.040
Why?
Chemokines
1
2017
77
0.040
Why?
Receptors, Collagen
1
1997
3
0.040
Why?
Receptors, Fibronectin
1
1997
5
0.040
Why?
Interferon-gamma
1
2018
174
0.040
Why?
Coculture Techniques
1
2017
146
0.040
Why?
Transforming Growth Factor beta
1
2018
144
0.040
Why?
Time Factors
4
2010
2912
0.040
Why?
Integrins
1
1997
31
0.040
Why?
Mass Screening
1
2000
351
0.040
Why?
Chemotherapy, Adjuvant
2
2010
121
0.040
Why?
Quality-Adjusted Life Years
2
2010
63
0.040
Why?
Diet, High-Fat
1
2019
222
0.040
Why?
Longitudinal Studies
1
2019
673
0.040
Why?
Hepatitis Viruses
1
2016
2
0.040
Why?
Epithelial Cells
2
2006
209
0.030
Why?
Herpesviridae
1
2016
17
0.030
Why?
Viruses
1
2016
21
0.030
Why?
Host-Pathogen Interactions
1
2017
129
0.030
Why?
Gastrointestinal Neoplasms
1
2016
44
0.030
Why?
Mice, Transgenic
1
2017
555
0.030
Why?
DNA Replication
1
1997
151
0.030
Why?
Plasmids
2
2001
159
0.030
Why?
Cost-Benefit Analysis
2
2010
273
0.030
Why?
Sequence Analysis, RNA
1
2016
91
0.030
Why?
Central Nervous System Neoplasms
1
2016
63
0.030
Why?
Fibroblasts
1
2017
343
0.030
Why?
Electrosurgery
1
1995
8
0.030
Why?
Macrophages
1
2018
364
0.030
Why?
CpG Islands
2
2008
107
0.030
Why?
DNA Probes, HPV
2
1991
3
0.030
Why?
Prostatic Neoplasms
1
1998
396
0.030
Why?
Computational Biology
1
2016
214
0.030
Why?
Arteries
1
1995
94
0.030
Why?
Cytokines
1
2017
612
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
18
0.030
Why?
Multivariate Analysis
2
2009
585
0.030
Why?
Treatment Failure
2
2008
113
0.030
Why?
Missouri
2
2006
65
0.030
Why?
Organs at Risk
1
2014
68
0.030
Why?
Inclusion Bodies
1
1993
17
0.030
Why?
Parathyroid Hormone-Related Protein
1
1993
23
0.030
Why?
Cell Division
2
1994
292
0.030
Why?
Cell Death
1
2014
181
0.030
Why?
Imaging, Three-Dimensional
1
2014
149
0.030
Why?
Risk
2
2004
320
0.030
Why?
Skin Physiological Phenomena
1
1992
15
0.030
Why?
Guinea Pigs
1
1992
74
0.030
Why?
Epidermis
1
1992
26
0.030
Why?
Pelvis
2
2004
68
0.030
Why?
Pedigree
2
2004
122
0.030
Why?
Deoxyglucose
1
2012
36
0.030
Why?
Regeneration
1
1992
72
0.030
Why?
Colectomy
1
1992
31
0.030
Why?
Computer Simulation
1
2012
282
0.020
Why?
Pilot Projects
2
2004
699
0.020
Why?
Sequence Deletion
2
2003
67
0.020
Why?
Premenopause
1
2010
24
0.020
Why?
Amino Acid Sequence
2
2003
587
0.020
Why?
Staurosporine
1
2010
12
0.020
Why?
Anastomosis, Surgical
1
1990
68
0.020
Why?
Remission Induction
1
2010
207
0.020
Why?
Molecular Weight
1
1990
84
0.020
Why?
Proto-Oncogene Proteins p21(ras)
2
2001
66
0.020
Why?
ras Proteins
2
2001
64
0.020
Why?
Cicatrix
1
1990
40
0.020
Why?
Hemoglobins
1
1990
108
0.020
Why?
Staining and Labeling
1
1990
97
0.020
Why?
Chi-Square Distribution
1
2010
282
0.020
Why?
Perioperative Care
1
2009
42
0.020
Why?
Urinary Incontinence
1
2009
38
0.020
Why?
Organoplatinum Compounds
1
2008
14
0.020
Why?
Gene Knockdown Techniques
1
2009
106
0.020
Why?
Vinblastine
1
2008
23
0.020
Why?
Fetus
1
1990
217
0.020
Why?
Life Style
1
2009
140
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
184
0.020
Why?
Emotions
1
2009
165
0.020
Why?
Demography
1
2007
93
0.020
Why?
Cadherins
1
2007
68
0.020
Why?
Cell Line
1
1990
1002
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2008
142
0.020
Why?
Cytoplasmic Structures
1
2006
1
0.020
Why?
Skin
1
1990
407
0.020
Why?
Waxes
1
2006
1
0.020
Why?
Tissue Embedding
1
2006
1
0.020
Why?
Eukaryotic Initiation Factor-2
1
2006
18
0.020
Why?
DNA Mismatch Repair
1
2006
17
0.020
Why?
NIH 3T3 Cells
1
2006
52
0.020
Why?
Immunoenzyme Techniques
2
2001
143
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2006
12
0.020
Why?
Chromosomal Instability
1
2006
16
0.020
Why?
Neoplasm, Residual
1
2007
166
0.020
Why?
Cryopreservation
1
2006
30
0.020
Why?
Genome, Viral
1
2006
79
0.020
Why?
Analysis of Variance
1
2007
565
0.020
Why?
Nurse Practitioners
1
2006
41
0.020
Why?
Mutation, Missense
1
2006
103
0.020
Why?
Transfection
1
2006
357
0.020
Why?
Gynecology
1
2006
49
0.020
Why?
Gene Expression
1
2008
608
0.020
Why?
Ovarian Cysts
1
2005
4
0.020
Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
Why?
Medical Futility
1
2005
8
0.020
Why?
Early Diagnosis
1
2006
87
0.020
Why?
Cyclophosphamide
1
2006
165
0.020
Why?
Triage
1
2006
64
0.020
Why?
Leiomyosarcoma
1
2005
23
0.020
Why?
Hospice Care
1
2005
27
0.020
Why?
Cytodiagnosis
1
2005
42
0.020
Why?
Health Services
1
2005
67
0.020
Why?
Phosphorylation
1
2006
536
0.020
Why?
Obstetrics
1
2006
88
0.020
Why?
Lymphatic System
1
2004
14
0.020
Why?
Penetrance
1
2004
6
0.020
Why?
Area Under Curve
1
2004
181
0.010
Why?
Microscopy, Electron, Transmission
1
2004
74
0.010
Why?
Calcification, Physiologic
1
2004
40
0.010
Why?
Laparotomy
1
2004
34
0.010
Why?
Bryostatins
1
2003
1
0.010
Why?
Macrolides
1
2003
16
0.010
Why?
Ethanol
1
2006
338
0.010
Why?
Genomic Instability
1
2004
92
0.010
Why?
Thrombospondin 1
1
2003
7
0.010
Why?
Tamoxifen
1
2004
60
0.010
Why?
Genes, p16
1
2003
9
0.010
Why?
Codon, Terminator
1
2003
8
0.010
Why?
Administration, Oral
1
2004
423
0.010
Why?
Confidence Intervals
1
2003
156
0.010
Why?
Frameshift Mutation
1
2003
17
0.010
Why?
Palliative Care
1
2005
187
0.010
Why?
Liposomes
1
2003
48
0.010
Why?
Mutagenesis, Insertional
1
2003
25
0.010
Why?
Body Weight
1
2005
513
0.010
Why?
Cytoskeletal Proteins
1
2003
49
0.010
Why?
DNA Transposable Elements
1
2003
107
0.010
Why?
Physicians
1
2006
234
0.010
Why?
Prevalence
1
2006
943
0.010
Why?
Reference Values
1
2003
310
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
beta Catenin
1
2003
102
0.010
Why?
Retinoblastoma Protein
1
2002
20
0.010
Why?
Ifosfamide
1
2002
9
0.010
Why?
Documentation
1
2002
33
0.010
Why?
Trans-Activators
1
2003
134
0.010
Why?
Bleomycin
1
2002
35
0.010
Why?
Hospitals, University
1
2002
77
0.010
Why?
Antineoplastic Agents, Alkylating
1
2002
74
0.010
Why?
Age Distribution
1
2002
170
0.010
Why?
Equipment Failure
1
2001
62
0.010
Why?
Statistics, Nonparametric
1
2002
197
0.010
Why?
Nucleic Acid Hybridization
2
1991
54
0.010
Why?
Antibiotics, Antineoplastic
1
2002
78
0.010
Why?
Carcinoma, Small Cell
1
2001
25
0.010
Why?
Genes, erbB-1
1
2001
8
0.010
Why?
Hospitalization
1
2005
653
0.010
Why?
Outpatients
1
2002
113
0.010
Why?
Radiography
1
2002
489
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2000
97
0.010
Why?
Mitogen-Activated Protein Kinases
1
2001
156
0.010
Why?
DNA
1
2004
545
0.010
Why?
Genetic Linkage
1
2000
26
0.010
Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
Why?
Morbidity
1
2000
138
0.010
Why?
Blotting, Western
1
2001
602
0.010
Why?
Gene Deletion
1
2000
266
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2001
152
0.010
Why?
Chromosomes, Bacterial
1
1998
14
0.010
Why?
Cloning, Molecular
1
1998
189
0.010
Why?
Infant
1
2006
3551
0.010
Why?
Child, Preschool
1
2006
3853
0.010
Why?
Drug Resistance, Multiple
1
1997
23
0.010
Why?
Antineoplastic Agents, Phytogenic
1
1997
69
0.010
Why?
Gene Frequency
1
1997
94
0.010
Why?
United States
1
2007
4838
0.010
Why?
Dimethyl Sulfoxide
1
1994
12
0.010
Why?
Ambulatory Surgical Procedures
1
1995
46
0.010
Why?
Glycerol
1
1994
15
0.010
Why?
Drug Carriers
1
1994
68
0.010
Why?
Drug Screening Assays, Antitumor
1
1994
136
0.010
Why?
Cell Cycle
1
1994
232
0.010
Why?
Retroperitoneal Space
1
1991
30
0.010
Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description